<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145274</url>
  </required_header>
  <id_info>
    <org_study_id>Allopurinol_2010_1</org_study_id>
    <nct_id>NCT01145274</nct_id>
  </id_info>
  <brief_title>A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient</brief_title>
  <acronym>Allopurinol</acronym>
  <official_title>A Pilot Study for PK/PD Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      To know the blood level of allopurinol in chronic kidney disease (CKD) patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the result of this pilot study, we can prescribe the optimal dose of allopurinol in CKD
      patient.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">February 2013</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        chronic kidney disease ( estimated GFR 30-60 ml/min )
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  from 18yrs to 80yrs , man and women

          -  the patient who are taking allopurinol

          -  On screening, the patient shows that the level of protein/creatinine ratio is over 3.0

          -  On screening, the patient shows that MDRD GFR &gt;= 30 ml/min and &lt;= 60 ml/min

          -  the patient sign on the concent form

        Exclusion Criteria:

          -  the patient have experience to take medication that have an effect on renal function

          -  the patient have experience to take cyclosporin within 3month

          -  At least, the average level of two separate blood pressure ( 2min interval ) shows
             that SBP &lt;= 100 mmHg or &gt;=160 mmHg and DBP &lt;=60 mmHg &gt;=100 mmHg, or Heart rate &lt; 40
             beats/min or &gt; 90 beats/min

          -  uncontrolled hypertension

          -  pregnancy or anticipate pregnancy with 6 month

          -  hypersensitivity to allopurinol

          -  acute hepatitis or the level of AST or ALT is over 2times of normal range or the level
             of bilirubin is over 2.0 mg/dL

          -  serum albumin &lt; 3.5 mg/dL or &gt; 5mg/dL

          -  urinary retension, prostatic hyperplasia

          -  the patient show gout attack on taking allopurinol

          -  the patient who have gastro-intestinal disease ( ex, crohn's disease, acute or chronic
             pancreatitis, ulcer )or who have the surgical history of gastrointestine.

          -  the patient who should take azathioprine, mercaptopurine, cyclophosphamide, Losartan,
             benzbromarone,fenofibrate,furosemide ,probenecid

          -  the patient who had taken part in the other study within 3months

          -  the patient who had gotten blood transfusion

          -  pregnant, breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ho Seok Koo, Dr</last_name>
    <phone>82-2-2072-2496</phone>
    <email>hoseok.koo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ho Seok Koo, Dr</last_name>
      <phone>82-2-2072-2496</phone>
      <email>hoseok.koo@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2010</study_first_submitted>
  <study_first_submitted_qc>June 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2010</study_first_posted>
  <last_update_submitted>August 12, 2011</last_update_submitted>
  <last_update_submitted_qc>August 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Suhnggwon Kim</name_title>
    <organization>Seoul National University Hospital</organization>
  </responsible_party>
  <keyword>allopurinol</keyword>
  <keyword>chronic kidney diseae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Allopurinol</mesh_term>
    <mesh_term>Oxypurinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

